If combination immunosuppressive therapy is used, patients should be given prophylaxis for opportunistic infections, such as Pneumocystis jirovecii (see prevention ofPneumocystis jiroveciipneumonia), and vaccines against common infections (eg, streptococcal pneumonia, influenza, COVID-19).